VITR — Vitrolife AB Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapFalling Star

Annual income statement for Vitrolife AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,246	1,681	3,234	3,512	3,609
Cost of Revenue
Gross Profit	768	1,046	1,780	1,978	2,139
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	876	1,245	2,602	7,101	2,826
Operating Profit	370	435	632	-3,589	783
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	366	460	537	-3,712	674
Provision for Income Taxes
Net Income After Taxes	288	344	394	-3,851	514
Minority Interest
Net Income Before Extraordinary Items
Net Income	287	341	394	-3,850	513
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	287	341	394	-3,851	513
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.58	3.62	3.03	-7.67	3.84
Dividends per Share